Cargando…

Clinical and Laboratory Improvement in Hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS) after COVID-19 Infection

A 32-year-old woman with a history of symptomatic supraventricular tachycardia, inappropriate sinus tachycardia, and hyperadrenergic POTS was treated with ivabradine and metoprolol. She then presented with bradycardia and Mobitz II second-degree AV block on event monitoring six weeks after COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales: Ocher, Rebecca A., Padilla, Erika, Hsu, Jonathan C., Taub, Pam R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405341/
https://www.ncbi.nlm.nih.gov/pubmed/34471549
http://dx.doi.org/10.1155/2021/7809231
_version_ 1783746313120120832
author Ocher, Rebecca A.
Padilla, Erika
Hsu, Jonathan C.
Taub, Pam R.
author_facet Ocher, Rebecca A.
Padilla, Erika
Hsu, Jonathan C.
Taub, Pam R.
author_sort Ocher, Rebecca A.
collection PubMed
description A 32-year-old woman with a history of symptomatic supraventricular tachycardia, inappropriate sinus tachycardia, and hyperadrenergic POTS was treated with ivabradine and metoprolol. She then presented with bradycardia and Mobitz II second-degree AV block on event monitoring six weeks after COVID-19 infection. Her post-viral workup revealed normalization of catecholamine levels and significant symptomatic improvement in heart rate. To the authors' knowledge, this is the first reported case of improvement in POTS after COVID-19 infection. As our understanding of COVID-19 continues to improve, it will be vital to better understand the impact of COVID-19 dysautonomia on cardiac patients.
format Online
Article
Text
id pubmed-8405341
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-84053412021-08-31 Clinical and Laboratory Improvement in Hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS) after COVID-19 Infection Ocher, Rebecca A. Padilla, Erika Hsu, Jonathan C. Taub, Pam R. Case Rep Cardiol Case Report A 32-year-old woman with a history of symptomatic supraventricular tachycardia, inappropriate sinus tachycardia, and hyperadrenergic POTS was treated with ivabradine and metoprolol. She then presented with bradycardia and Mobitz II second-degree AV block on event monitoring six weeks after COVID-19 infection. Her post-viral workup revealed normalization of catecholamine levels and significant symptomatic improvement in heart rate. To the authors' knowledge, this is the first reported case of improvement in POTS after COVID-19 infection. As our understanding of COVID-19 continues to improve, it will be vital to better understand the impact of COVID-19 dysautonomia on cardiac patients. Hindawi 2021-08-18 /pmc/articles/PMC8405341/ /pubmed/34471549 http://dx.doi.org/10.1155/2021/7809231 Text en Copyright © 2021 Rebecca A. Ocher et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Ocher, Rebecca A.
Padilla, Erika
Hsu, Jonathan C.
Taub, Pam R.
Clinical and Laboratory Improvement in Hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS) after COVID-19 Infection
title Clinical and Laboratory Improvement in Hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS) after COVID-19 Infection
title_full Clinical and Laboratory Improvement in Hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS) after COVID-19 Infection
title_fullStr Clinical and Laboratory Improvement in Hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS) after COVID-19 Infection
title_full_unstemmed Clinical and Laboratory Improvement in Hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS) after COVID-19 Infection
title_short Clinical and Laboratory Improvement in Hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS) after COVID-19 Infection
title_sort clinical and laboratory improvement in hyperadrenergic postural orthostatic tachycardia syndrome (pots) after covid-19 infection
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405341/
https://www.ncbi.nlm.nih.gov/pubmed/34471549
http://dx.doi.org/10.1155/2021/7809231
work_keys_str_mv AT ocherrebeccaa clinicalandlaboratoryimprovementinhyperadrenergicposturalorthostatictachycardiasyndromepotsaftercovid19infection
AT padillaerika clinicalandlaboratoryimprovementinhyperadrenergicposturalorthostatictachycardiasyndromepotsaftercovid19infection
AT hsujonathanc clinicalandlaboratoryimprovementinhyperadrenergicposturalorthostatictachycardiasyndromepotsaftercovid19infection
AT taubpamr clinicalandlaboratoryimprovementinhyperadrenergicposturalorthostatictachycardiasyndromepotsaftercovid19infection